Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis
Nosha Farhadfar(University of Florida Health), John R. Wingard(University of Florida Health), Melhem Solh(Johns Hopkins Hospital), Michael A. Pulsipher(Primary Children's Hospital), Siddhartha Ganguly(University of Kansas Medical Center), Maxim Norkin(University of Florida Health), Nayesh R. Kamani(Children's National), Jennifer A. Sees(National Marrow Donor Program), Galen E. Switzer(University of Pittsburgh), Haydar Frangoul(Children’s Hospital at TriStar Centennial), Kimberly A. Kasow(University of North Carolina at Chapel Hill), Hemant S. Murthy(University of Florida), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Saurabh Chhabra(Medical College of Wisconsin), Nirali N. Shah(National Institutes of Health), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Michael Linenberger(Fred Hutch Cancer Center), Thomas R. Spitzer(Harvard University), Amer Beitinjaneh(University of Miami), Raquel M. Schears(Mayo Clinic in Arizona), Hillard M. Lazarus(University Hospitals of Cleveland), Katie Engles(National Marrow Donor Program), Sachiko Seo(National Cancer Center Hospital East), Paul V. O’ Donnell(Massachusetts General Hospital), Usama Gergis(Thomas Jefferson University Hospital), Joseph E. Schwartz(Columbia University Irving Medical Center), Richard F. Olsson(AstraZeneca (Netherlands)), Minoo Battiwalla(Sarah Cannon), Jane L. Liesveld(Strong Memorial Hospital), Mouhab Ayas(King Faisal Specialist Hospital & Research Centre), Susan Rossmann, Bipin N. Savani(Vanderbilt University Medical Center), Michele W. Sugrue(University of Florida), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Jean A. Yared(University of Maryland, Baltimore), Rammurti T. Kamble(Baylor College of Medicine), Dennis L. Confer(National Marrow Donor Program)
Cited by 13
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k